Dr. Abreu is the director of the Crohn’s and Colitis Center at the University of Miami and current vice president of the AGA, according to a Jan. 19 news release. She will assume the role of president for the AGA in 2024.
She also served as a past chair of the International Organization for the Study of Inflammatory Bowel Disease and was a recipient of the Sherman Prize, an award given to the nation’s most distinguished inflammatory bowel disease researchers, in 2019.
“I am thrilled to partner with Dr. Abreu to build a world where every single patient with IBD has access to comprehensive, evidenced-based, multidisciplinary GI care,” Sameer Berry, MD, CMO of Oshi Health said in the release. “She has the rare combination of research and clinical expertise in IBD, along with a pragmatic approach to building the future of care delivery in gastroenterology.”
Dr. Abreu will serve on the board alongside Gil Melmed, MD, of Cedars-Sinai Medical Center in Los Angeles, and John Allen, MD, retired chief clinical officer at Ann Arbor-based University of Michigan Medical Group and past president and chairman of the AGA.
